EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 69; no. 1; pp. 182 - 236
Main Authors: Galle, Peter R., Forner, Alejandro, Llovet, Josep M., Mazzaferro, Vincenzo, Piscaglia, Fabio, Raoul, Jean-Luc, Schirmacher, Peter, Vilgrain, Valérie
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01.07.2018
Elsevier Science Ltd
Subjects:
Carcinoma, Hepatocellular - therapy
Clinical medicine
Clinical practice guidelines
Decision making
Disease Management
Europe
Gastroenterology
Hepatocellular carcinoma
Humans
Liver cancer
Liver Neoplasms - therapy
Practice Guidelines as Topic
Societies, Medical
Europe
ISSN:0168-8278, 1600-0641, 1600-0641
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0168-8278
1600-0641
1600-0641
DOI:10.1016/j.jhep.2018.03.019